PI3Kδ Inhibition as a Potential Therapeutic Target in COVID-19-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

PI3Kδ Inhibition as a Potential Therapeutic Target in COVID-19

Published:2020-08-21 Issue: Volume:11 Page:
ISSN:1664-3224
Container-title:Frontiers in Immunology
language:
Short-container-title:Front. Immunol.

Author:

Palma Giuseppe,Pasqua Teresa,Silvestri Giovannino,Rocca Carmine,Gualtieri Paola,Barbieri Antonio,De Bartolo Anna,De Lorenzo Antonino,Angelone Tommaso,Avolio Ennio,Botti Gerardo

Publisher

Frontiers Media SA

Subject

Immunology,Immunology and Allergy

Reference79 articles.

1. Emerging coronaviruses: genome structure, replication, and pathogenesis.;Chen;J Med Virol.,2020

2. A new coronavirus associated with human respiratory disease in China.;Wu;Nature.,2020

3. A pneumonia outbreak associated with a new coronavirus of probable bat origin.;Zhou;Nature.,2020

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Drug repurposing of cyclin-dependent kinase inhibitors for neutrophilic acute respiratory distress syndrome and psoriasis;Journal of Advanced Research;2024-07

2. Discovery of Highly Selective and Orally Bioavailable PI3Kδ Inhibitors with Anti-Inflammatory Activity for Treatment of Acute Lung Injury;Journal of Medicinal Chemistry;2023-08-22

3. Palbociclib blocks neutrophilic phosphatidylinositol 3‐kinase activity to alleviate psoriasiform dermatitis;British Journal of Pharmacology;2023-04-19

4. Severe COVID-19: Drugs and Clinical Trials;Journal of Clinical Medicine;2023-04-16

5. Dysregulated Neutrophil Phenotype and Function in Hospitalised Non-ICU COVID-19 Pneumonia;Cells;2022-09-16

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP